About Saira Ramasastry
Saira Ramasastry is a director at Mirum Pharmaceuticals.
Form D filings name Saira Ramasastry as a director at Kriya Therapeutics.
Saira Ramasastry reports to the SEC as a director of 9 public companies, including Faeth Therapeutics (FTH), Day One Biopharmaceuticals (DAWN) and Vir Biotechnology (VIR).
Saira Ramasastry first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Saira Ramasastry in the role, so the role may have started earlier or lasted longer.
MI
Mirum Pharmaceuticals, Inc.
Director
2022 – 2026 · Public company (MIRM)
FI
Faeth Therapeutics, Inc.
Director
2026 · Public company (FTH)
DI
Day One Biopharmaceuticals, Inc.
Director
2021 – 2026 · Public company (DAWN)
VI
Vir Biotechnology, Inc.
Director
2019 – 2025 · Public company (VIR)
AI
Akouos, Inc.
Director
2020 – 2022 · Public company (AKUS)
SI
Sangamo Therapeutics, Inc.
Director
2012 – 2022 · Public company (SGMO)
9I
9 Meters Biopharma, Inc.
Director
2018 – 2020 · Public company (NMTR)
FI
Filana Therapeutics, Inc.
Director
2013 – 2019 · Public company (FLNA)
RI
Repros Therapeutics Inc.
Director
2013 – 2018 · Public company (RPRX)
Key Colleagues at Startups
The people Saira Ramasastry works with at each company, as listed on that company's latest Form D.
Kriya Therapeutics, Inc. · Form D/A, Sep 10, 2025
NV
Neelaksh Varshney
Director
MS
Michele Stone
Executive officer
IO
Ilan Oren
Director
RG
Ryan Gallagher
Director
KM
Keith Manchester
Director
KE
Katherine Eade
Executive officer
JM
James Momtazee
Director
AR
Akshay Rai
Director
SR
Shankar Ramaswamy
Chief Executive Officer and director
CH
Curt Herberts
Executive officer
BP
Britt Petty
Executive officer
RJ
Roger Jeffs
Director
BF
Brian Furmanski
Executive officer
TG
Trit Garg
Director